A Study of ARRY-334543 and Capecitabine in Patients With Advanced Cancer
Clinical trial NCT00710736 · COMPLETED
Trial details
- NCT number
- NCT00710736
- Sponsor
- Array Biopharma, now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2011-04-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.